EP 1206541 A4 20020918 - DENDRITIC ENRICHED SECRETED LYMPHOCYTE ACTIVATION MOLECULE
Title (en)
DENDRITIC ENRICHED SECRETED LYMPHOCYTE ACTIVATION MOLECULE
Title (de)
ÜBER DENDRITISCHE ZELLEN ANGEREICHERTES, SEKRETIERTES LYMPHOZYTEN-AKTIVIERUNGSMOLEKüL
Title (fr)
MOLECULE D'ACTIVATION LYMPHOCYTAIRE SECRETEE DE MANIERE ENRICHIE PAR DES CELLULES DENDRITIQUES
Publication
Application
Priority
- US 0021130 W 20000803
- US 36924899 A 19990805
- US 19006200 P 20000317
Abstract (en)
[origin: WO0111046A1] The present invention relates to a novel human protein called Dendritic Enriched Secreted Lymphocyte Activation Molecule, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 1/00 (2006.01); A61P 1/02 (2006.01); A61P 1/04 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 11/00 (2006.01); A61P 17/00 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 25/00 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 37/04 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 1/02 (2017.12); A61P 1/04 (2017.12); A61P 3/10 (2017.12); A61P 9/00 (2017.12); A61P 11/00 (2017.12); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 19/00 (2017.12); A61P 25/00 (2017.12); A61P 31/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 37/04 (2017.12); C07K 14/47 (2013.01); A61K 48/00 (2013.01)
Citation (search report)
- [LPX] WO 9940184 A1 19990812 - HUMAN GENOME SCIENCES INC [US], et al
- [PX] WO 0018800 A1 20000406 - MILLENNIUM BIOTHERAPEUTICS INC [US], et al
- See references of WO 0111046A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0111046 A1 20010215; AU 6619400 A 20010305; CA 2382659 A1 20010215; EP 1206541 A1 20020522; EP 1206541 A4 20020918; JP 2003506087 A 20030218
DOCDB simple family (application)
US 0021130 W 20000803; AU 6619400 A 20000803; CA 2382659 A 20000803; EP 00953810 A 20000803; JP 2001515832 A 20000803